Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Revenue of Armata Pharmaceuticals, Inc. (ARMP)
Revenue in 2023 (TTM): $4.53 M
According to Armata Pharmaceuticals, Inc.'s latest financial reports the company's current revenue (TTM) is $4.53 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history of Armata Pharmaceuticals, Inc.
Annual Revenue
| Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
|---|---|---|---|---|---|
| 2023 | $4.53 M | $-29,241,000 | $-39,918,000 | $-69,045,000 | $-69,045,000 |
| 2022 | $5.51 M | $4.62 M | $-36,054,000 | $-36,917,000 | $-36,888,000 |
| 2021 | $4.47 M | $-15,541,000 | $-22,653,000 | $-23,155,000 | $-23,219,000 |
| 2020 | $823 K | $-13,621,000 | $-20,439,000 | $-22,181,000 | $-22,815,000 |
| 2019 | $ | $-1,351,000 | $-19,752,000 | $-19,479,000 | $-19,025,000 |
| 2018 | $ | $-1,351,000 | $-9,540,000 | $-12,438,000 | $-12,110,000 |
| 2017 | $115 K | $-259,000 | $-9,982,000 | $-14,140,000 | $-12,838,000 |
| 2016 | $260 K | $-109,000 | $-13,462,000 | $-19,394,000 | $-18,838,000 |
| 2015 | $475 K | $475 K | $-10,227,000 | $-589,000 | $-516,000 |
| 2014 | $409 K | $409 K | $-14,110,000 | $23.11 M | $23.11 M |
| 2013 | $325 K | $325 K | $-61,601,000 | $-58,411,000 | $-58,411,000 |
| 2012 | $664 K | $664 K | $-3,861,000 | $-4,260,000 | $-1,110,000 |
| 2009 | $12.17 M | $ | $7.95 M | $7.95 M | $7.95 M |
| 2008 | $8.72 M | $8.72 M | $-11,771,000 | $-20,720,000 | $-20,720,000 |
| 2007 | $10.33 M | $10.33 M | $-13,804,000 | $-16,127,000 | $-16,127,000 |
| 2006 | $9.86 M | $9.86 M | $-32,859,000 | $-33,990,000 | $-33,990,000 |
| 2005 | $6.87 M | $6.87 M | $-17,367,000 | $-19,198,000 | $-19,198,000 |
| 2004 | $9.65 M | $9.65 M | $-12,492,000 | $-14,257,000 | $-14,257,000 |
| 2003 | $14.07 M | $14.07 M | $-6,194,000 | $-14,833,000 | $-14,833,000 |
| 2002 | $19.33 M | $19.33 M | $-16,800,000 | $-23,767,000 | $-23,767,000 |
| 2001 | $18.88 M | $18.88 M | $-19,912,000 | $-27,170,000 | $-27,170,000 |
| 2000 | $11.4 M | $13.18 M | $-42,344,000 | $-47,655,691 | $-47,655,691 |
| 1999 | $6.8 M | $8.4 M | $-9,500,000 | $-26,700,000 | $-26,700,000 |
| 1998 | $7.2 M | $8.8 M | $-7,500,000 | $-8,700,000 | $-8,700,000 |
| 1997 | $900 K | $2.5 M | $-13,300,000 | $-14,200,000 | $-14,200,000 |
| 1996 | $2.3 M | $4.2 M | $-10,200,000 | $-26,000,000 | $-26,000,000 |
| 1995 | $100 K | $1.5 M | $-9,000,000 | $-9,900,000 | $-9,900,000 |
| 1994 | $400 K | $1.7 M | $-7,000,000 | $-8,400,000 | $-8,400,000 |
| 1993 | $100 K | $500 K | $-5,000,000 | $-5,100,000 | $-5,100,000 |